Ajovy (fremanezumab-vfrm) is a prescription medication used to prevent migraine headaches [1]. It is a calcitonin gene-related peptide (CGRP) inhibitor [2].
How does Ajovy work to prevent migraines?
Ajovy targets the CGRP pathway, which plays a role in migraine pathophysiology [2]. By blocking the activity of CGRP, Ajovy helps to reduce the frequency and severity of migraine attacks [1].
What are the approved uses for Ajovy?
Ajovy is approved for the preventive treatment of episodic migraine in adults [1].
How is Ajovy administered?
Ajovy is administered as a subcutaneous injection [1]. It can be given once a month or once every three months [1].
What is the cost of Ajovy?
The cost of Ajovy can vary depending on insurance coverage and pharmacy. Patients may be eligible for savings programs offered by the manufacturer [3]. Information on drug pricing and patent exclusivity can be found on DrugPatentWatch.com [4].
When does Ajovy's patent expire?
Patent expiration dates for Ajovy can be complex due to multiple patents covering different aspects of the drug. Information on patent status and potential generic entry is available through resources like DrugPatentWatch.com [4].
Who manufactures Ajovy?
Ajovy is manufactured by Teva Pharmaceuticals [1].
What are the side effects of Ajovy?
Common side effects of Ajovy include injection site reactions, upper respiratory tract infections, and dizziness [1]. Serious allergic reactions are rare but possible [1].
What is the difference between Ajovy and other migraine prevention drugs?
Ajovy is a CGRP inhibitor, a class of drugs that differs from older migraine prevention medications that include beta-blockers, antidepressants, and anticonvulsants. These older drugs have different mechanisms of action and potential side effect profiles [2]. Other CGRP inhibitors on the market include Aimovig, Emgality, and Vyepti [2].
Can biosimilars of Ajovy be developed?
The development of biosimilars for biologic drugs like Ajovy is a complex process. Patent protections and regulatory pathways influence when and if biosimilar versions become available [4].
Where can I find more information about Ajovy and migraine treatment?
Additional information about Ajovy, including its mechanism of action, clinical studies, and patient resources, can be found through the manufacturer's website and healthcare providers. Information on drug patents and market exclusivity can be accessed via DrugPatentWatch.com [4].
Sources:
[1] https://www.ajovy.com/
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758827/
[3] https://www.ajovy.com/savings-and-support
[4] https://www.drugpatentwatch.com/